As HotCopper Diary pointed out in its news section some time ago (http://hotcopper.com.au/resources/cudeco-boss-hunts-down-shareholder-over-posts.139/#.Vqf5OCp96hc), lawsuits to silence critical commentary usually end very badly for the company. They were referencing Cudeco, who sued HC to find the identity of a poster.
Within a short time the founder chairman Wayne McCrae was pushed out by shareholders:
http://www.smh.com.au/business/mini...ut-by-major-shareholders-20150724-gijleu.html
Then the shareholders revolted:
http://www.goldcoastbulletin.com.au...t/news-story/d74ec54a6ef1ec573908fa3df00ef2a6
Then the new chairman resigned just a week ago:
http://www.goldcoastbulletin.com.au...y/news-story/5ff3087701d9835a93ffc9afdeac820f
Meanwhile, the sp has fallen from $1.70 to $1.11, and there are whispers about its viability. So while legal intimidation may seem tempting for OSL management, I think maybe allowing public debate about a public company may prove to be the wisest course.
- Forums
- ASX - By Stock
- OSL
- The Australian
OSL
oncosil medical ltd
Add to My Watchlist
5.69%
!
$1.16

The Australian, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M |
Open | High | Low | Value | Volume |
$1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9286 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 412 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9286 | 1.160 |
1 | 7500 | 1.080 |
2 | 19761 | 1.050 |
1 | 2500 | 1.030 |
1 | 550 | 1.020 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 412 | 1 |
1.200 | 8677 | 1 |
1.245 | 2418 | 1 |
1.250 | 46027 | 1 |
1.300 | 1500 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online